Avrobio Inc (DELISTED) (AVRO:DL)
16.80
-0.24
(-1.41%)
USD |
NASDAQ |
Jun 20, 16:00
Avrobio Shares Outstanding: 14.73M for June 21, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
June 21, 2024 | 14.73M |
May 02, 2024 | 3.741M |
April 29, 2024 | 3.741M |
March 31, 2024 | 3.740M |
March 15, 2024 | 3.740M |
March 07, 2024 | 3.738M |
January 26, 2024 | 3.722M |
December 31, 2023 | 3.721M |
November 02, 2023 | 3.714M |
September 30, 2023 | 3.713M |
August 03, 2023 | 3.711M |
June 30, 2023 | 3.692M |
May 04, 2023 | 3.675M |
April 10, 2023 | 3.675M |
March 31, 2023 | 3.674M |
March 16, 2023 | 3.674M |
December 31, 2022 | 3.660M |
November 03, 2022 | 3.648M |
November 01, 2022 | 3.648M |
September 30, 2022 | 3.648M |
August 02, 2022 | 3.648M |
June 30, 2022 | 3.641M |
May 03, 2022 | 3.641M |
April 11, 2022 | 3.641M |
March 31, 2022 | 3.641M |
Date | Value |
---|---|
March 10, 2022 | 3.641M |
December 31, 2021 | 3.638M |
October 29, 2021 | 3.638M |
September 30, 2021 | 3.636M |
July 30, 2021 | 3.635M |
June 30, 2021 | 3.635M |
May 06, 2021 | 3.480M |
April 12, 2021 | 3.480M |
March 31, 2021 | 3.480M |
March 09, 2021 | 3.468M |
December 31, 2020 | 3.464M |
November 24, 2020 | 3.454M |
October 30, 2020 | 3.038M |
September 30, 2020 | 3.037M |
July 31, 2020 | 3.037M |
June 30, 2020 | 3.036M |
April 30, 2020 | 3.003M |
April 06, 2020 | 3.003M |
March 31, 2020 | 3.001M |
March 06, 2020 | 3.002M |
February 18, 2020 | 2.999M |
December 31, 2019 | 2.637M |
November 05, 2019 | 2.639M |
September 30, 2019 | 2.634M |
August 05, 2019 | 2.639M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
2.637M
Minimum
Dec 31 2019
14.73M
Maximum
Jun 21 2024
3.715M
Average
3.641M
Median
Shares Outstanding Benchmarks
Agenus Inc | 21.57M |
BioCryst Pharmaceuticals Inc | 206.89M |
AIM ImmunoTech Inc | 63.32M |
Protalix BioTherapeutics Inc | 73.54M |
Armata Pharmaceuticals Inc | 36.18M |